POTENTIAL TARGETS FROM HUMAN (RESULTS FROM SUB-STRUCTURAL SIMILARITY SEARCHES)1) User may click on the DrReposER ID (the second column) to get information on the binding sites and drug molecule.
2) Click View (the second last column) to view matched residues and superposition in the NGL viewer (upper right part).
3) User may also click on the Dock (the last column) to get script for molecular docking in UCSF Chimera through AutoDock Vina.

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V95_A_HCYA1375_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	1ism	BONE MARROW STROMAL CELL ANTIGEN 1 (Homo sapiens)	5 / 12	ALA A 20 ARG A 23 ILE A 38 ASP A 34 PHE A 15	None	1.25A	21.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V95_A_HCYA1375_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	1jhw	MACROPHAGE CAPPING PROTEIN (Homo sapiens)	5 / 12	ALA A 266 VAL A 265 GLN A 332 ILE A 277 PHE A 282	None	1.20A	20.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V95_A_HCYA1375_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2jdx	PROTEIN (L-ARGININE:GLYCINE AMIDINOTRANSFERASE) (Homo sapiens)	5 / 12	ALA A 261 THR A 307 PHE A 296 ILE A 294 PHE A 308	None	1.19A	20.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V95_A_HCYA1375_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2nz1	SMALL INDUCIBLE CYTOKINE A2 (Homo sapiens)	5 / 12	ALA D 53 VAL D 41 ILE D 64 LYS D 58 TRP D 59	None	1.25A	11.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V95_A_HCYA1375_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2q9g	CYTOCHROME P450 46A1 (Homo sapiens)	5 / 12	THR A 298 PHE A 299 ILE A 141 ASP A 142 TRP A 134	None HEM A 505 (-4.0A) None None HEM A 505 (-3.7A)	1.19A	23.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V95_A_HCYA1375_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	3ud2	ANKYRIN-1 (Homo sapiens)	5 / 12	ALA C 945 PRO C 946 THR C1057 ILE C 938 PHE C 985	None	1.30A	23.51
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V95_A_HCYA1375_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4aej	COLLAGEN ALPHA-1(III) CHAIN (Homo sapiens)	5 / 12	ALA A 84 VAL A 239 PHE A 235 ILE A 223 ASP A 222	None	1.30A	21.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2V95_A_HCYA1375_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	8 / 12	ALA A 18 VAL A 22 GLN A 232 THR A 240 PHE A 242 ARG A 260 ILE A 263 PHE A 366	None	1.04A	61.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V95_A_HCYA1375_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4l6e	E3 SUMO-PROTEIN LIGASE RANBP2 (Homo sapiens)	5 / 12	ALA A2938 VAL A3022 THR A3036 ILE A2971 PHE A3033	None	1.10A	18.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V95_A_HCYA1375_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4p22	UBIQUITIN-LIKE MODIFIER-ACTIVATING ENZYME 1 (Homo sapiens)	5 / 12	VAL A 248 THR A 274 ILE A 277 ASP A 51 PHE A 275	None	1.27A	22.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V95_A_HCYA1375_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4uom	FAB FRAGMENT HEAVY CHAIN FAB FRAGMENT LIGHT CHAIN (Homo sapiens)	5 / 12	VAL L 59 THR H 101 ARG L 55 ILE L 49 ASP L 53	None	1.31A	21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V95_A_HCYA1375_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5h64	SERINE/THREONINE-PRO TEIN KINASE MTOR (Homo sapiens)	5 / 12	PRO A1116 VAL A1119 GLN A1183 ARG A1154 ILE A1155	None	1.11A	9.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2V95_A_HCYA1375_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	6bf6	INSULIN-DEGRADING ENZYME (Homo sapiens)	5 / 12	PRO A 837 GLN A 770 PHE A1005 ARG A 839 ILE A 843	None	1.16A	13.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	1hi2	EOSINOPHIL-DERIVED NEUROTOXIN (Homo sapiens)	5 / 12	THR A 42 ILE A 30 ASN A 31 PHE A 43 HIS A 82	None	1.43A	15.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2bo9	HUMAN LATEXIN (Homo sapiens)	5 / 12	VAL B 58 PHE B 89 ILE B 21 ASN B 22 PHE B 91	None	1.33A	19.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2gf9	RAS-RELATED PROTEIN RAB-3D (Homo sapiens)	5 / 12	VAL A 180 ARG A 66 ILE A 71 SER A 19 PHE A 23	None	1.42A	20.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2nvu	MALTOSE BINDING PROTEIN/NEDD8-ACTIVA TING ENZYME E1 CATALYTIC SUBUNIT CHIMERA NEDD8-CONJUGATING ENZYME UBC12 (Homo sapiens)	5 / 12	SER B2396 PHE C 80 ILE C 125 ASN C 126 PHE C 60	None	1.39A	17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2r0b	SERINE/THREONINE/TYR OSINE-INTERACTING PROTEIN (Homo sapiens)	5 / 12	THR A 102 PHE A 130 ILE A 95 ASN A 94 PHE A 99	None	1.28A	18.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4a2y	EOSINOPHIL CATIONIC PROTEIN (Homo sapiens)	5 / 12	THR A 42 ILE A 30 ASN A 31 PHE A 43 HIS A 82	None	1.47A	14.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	GLN A 232 PHE A 242 ASN A 264 SER A 267 HIS A 368	None	1.17A	96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	GLN A 232 THR A 240 PHE A 242 ASN A 264 SER A 267	None	0.85A	96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	SER A 19 VAL A 22 GLN A 232 ARG A 260 PHE A 366	None	1.10A	96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	7 / 12	VAL A 22 GLN A 232 PHE A 242 ILE A 263 ASN A 264 PHE A 366 HIS A 368	None	0.96A	96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	7 / 12	VAL A 22 GLN A 232 THR A 240 PHE A 242 ARG A 260 ILE A 263 PHE A 366	None	1.13A	96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	7 / 12	VAL A 22 GLN A 232 THR A 240 PHE A 242 ILE A 263 ASN A 264 PHE A 366	None	0.67A	96.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4e93	TYROSINE-PROTEIN KINASE FES/FPS (Homo sapiens)	5 / 12	SER A 494 VAL A 495 GLN A 535 THR A 533 HIS A 529	None	1.22A	21.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4nen	INTEGRIN ALPHA-X (Homo sapiens)	5 / 12	SER A 767 VAL A 786 THR A 842 PHE A 802 HIS A 804	None	1.35A	16.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5d2n	C25 BETA (Homo sapiens)	5 / 12	SER F 7 GLN F 54 THR F 47 PHE F 49 ARG F 22	None	1.02A	24.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5e13	NON-SECRETORY RIBONUCLEASE (Homo sapiens)	5 / 12	THR A 42 ILE A 30 ASN A 31 PHE A 43 HIS A 82	None	1.44A	16.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5erd	DESMOGLEIN-2 (Homo sapiens)	5 / 12	SER A 148 GLN A 112 PHE A 115 ILE A 132 PHE A 110	None	1.32A	20.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5wde	KINESIN-LIKE PROTEIN KIFC3 (Homo sapiens)	5 / 12	SER A 746 VAL A 452 ILE A 479 SER A 489 PHE A 471	None None None UNX A 920 ( 4.4A) None	1.33A	21.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5wt7	PERIOSTIN (Homo sapiens)	5 / 12	VAL A 112 GLN A 97 ILE A 101 SER A 99 PHE A 42	None	1.41A	13.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	6bf6	INSULIN-DEGRADING ENZYME (Homo sapiens)	5 / 12	GLN A 770 PHE A1005 ARG A 839 ILE A 843 HIS A 952	None	1.32A	13.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	6fyh	E3 UBIQUITIN-PROTEIN LIGASE HUWE1 (Homo sapiens)	5 / 12	SER A 315 VAL A 317 THR A 277 ILE A 268 PHE A 322	None	1.39A	12.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	1hi2	EOSINOPHIL-DERIVED NEUROTOXIN (Homo sapiens)	5 / 12	THR A 42 ILE A 30 ASN A 31 PHE A 43 HIS A 82	None	1.35A	15.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2nvu	MALTOSE BINDING PROTEIN/NEDD8-ACTIVA TING ENZYME E1 CATALYTIC SUBUNIT CHIMERA NEDD8-CONJUGATING ENZYME UBC12 (Homo sapiens)	5 / 12	SER B2396 PHE C 80 ILE C 125 ASN C 126 PHE C 60	None	1.28A	17.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2r0b	SERINE/THREONINE/TYR OSINE-INTERACTING PROTEIN (Homo sapiens)	5 / 12	THR A 102 PHE A 130 ILE A 95 ASN A 94 PHE A 99	None	1.15A	18.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	3dwb	ENDOTHELIN-CONVERTIN G ENZYME 1 (Homo sapiens)	5 / 12	SER A 634 THR A 610 PHE A 475 SER A 478 PHE A 613	None	1.42A	20.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	3fed	GLUTAMATE CARBOXYPEPTIDASE III (Homo sapiens)	5 / 12	THR A 379 ILE A 86 SER A 410 PHE A 67 HIS A 72	None	1.28A	21.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	3llr	DNA (CYTOSINE-5)-METHYLT RANSFERASE 3A (Homo sapiens)	5 / 12	SER A 103 PHE A 80 ILE A 133 ASN A 129 PHE A 76	None	1.40A	18.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	3wlw	ANTIBODY L CHAIN (Homo sapiens)	5 / 12	SER L 11 VAL L 10 PHE L 64 ILE L 77 HIS L 41	None	1.33A	19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4a2y	EOSINOPHIL CATIONIC PROTEIN (Homo sapiens)	5 / 12	THR A 42 ILE A 30 ASN A 31 PHE A 43 HIS A 82	None	1.39A	14.68
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	7 / 12	SER A 19 VAL A 22 GLN A 232 PHE A 242 ARG A 260 ILE A 263 PHE A 366	None	1.04A	96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	8 / 12	VAL A 22 GLN A 232 THR A 240 PHE A 242 ARG A 260 ILE A 263 SER A 267 PHE A 366	None	0.98A	96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	8 / 12	VAL A 22 GLN A 232 THR A 240 PHE A 242 ILE A 263 ASN A 264 PHE A 366 HIS A 368	None	0.83A	96.25
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	8 / 12	VAL A 22 GLN A 232 THR A 240 PHE A 242 ILE A 263 ASN A 264 SER A 267 PHE A 366	None	0.63A	96.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4nen	INTEGRIN ALPHA-X (Homo sapiens)	5 / 12	SER A 767 VAL A 786 THR A 842 PHE A 802 HIS A 804	None	1.26A	16.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4nik	SINGLE-CHAIN FV FRAGMENT ANTIBODY (Homo sapiens)	5 / 12	SER B 145 VAL B 144 PHE B 198 ILE B 211 HIS B 175	None	1.45A	22.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4rh7	GREEN FLUORESCENT PROTEIN/CYTOPLASMIC DYNEIN 2 HEAVY CHAIN 1 (Homo sapiens; synthetic construct)	5 / 12	SER A1842 THR A1906 PHE A1918 ILE A1848 SER A1852	None	1.25A	8.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4wgk	NEUTRAL CERAMIDASE (Homo sapiens)	5 / 12	VAL A 314 GLN A 218 ILE A 118 SER A 216 HIS A 222	None	1.40A	22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5drz	HIV ANTIBODY F240 HEAVY CHAIN HIV ANTIBODY F240 LIGHT CHAIN (Homo sapiens)	5 / 12	PHE H 100 ARG H 38 ILE H 37 SER H 35 PHE L 98	None	1.42A	21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5e13	NON-SECRETORY RIBONUCLEASE (Homo sapiens)	5 / 12	THR A 42 ILE A 30 ASN A 31 PHE A 43 HIS A 82	None	1.36A	16.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5h9p	GALECTIN-3 (Homo sapiens)	5 / 12	PHE A 192 ARG A 144 ILE A 145 ASN A 160 PHE A 163	None TD2 A 301 (-3.5A) None TD2 A 301 (-4.0A) None	1.45A	17.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5hdh	TOLL-LIKE RECEPTOR 8 (Homo sapiens)	5 / 12	SER A 152 PHE A 83 ILE A 92 ASN A 93 PHE A 121	None	1.44A	20.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2VDY_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	6bf6	INSULIN-DEGRADING ENZYME (Homo sapiens)	5 / 12	GLN A 770 PHE A1005 ARG A 839 ILE A 843 HIS A 952	None	1.22A	13.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	1p1v	SUPEROXIDE DISMUTASE [CU-ZN] (Homo sapiens)	5 / 12	ALA A 95 SER A 34 VAL A 97 PHE A 45 HIS A 120	None None None None ZN A 201 ( 3.2A)	1.11A	16.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	1z5v	TUBULIN GAMMA-1 CHAIN (Homo sapiens)	5 / 12	SER A 140 VAL A 171 GLN A 230 ILE A 228 SER A 226	GSP A2466 (-3.1A) None None GSP A2466 (-4.5A) None	1.28A	21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2a2a	DEATH-ASSOCIATED PROTEIN KINASE 2 (Homo sapiens)	5 / 12	ALA A 25 SER A 21 VAL A 27 ILE A 160 ASN A 144	None None None GOL A3001 ( 3.9A) None	0.98A	21.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2bo9	HUMAN LATEXIN (Homo sapiens)	5 / 12	VAL B 58 PHE B 89 ILE B 21 ASN B 22 PHE B 91	None	1.23A	18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2jdx	PROTEIN (L-ARGININE:GLYCINE AMIDINOTRANSFERASE) (Homo sapiens)	5 / 12	ALA A 261 THR A 307 PHE A 296 ILE A 294 PHE A 308	None	1.16A	23.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2r0b	SERINE/THREONINE/TYR OSINE-INTERACTING PROTEIN (Homo sapiens)	5 / 12	THR A 102 PHE A 130 ILE A 95 ASN A 94 PHE A 99	None	1.27A	18.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2v9k	UNCHARACTERIZED PROTEIN FLJ32312 (Homo sapiens)	5 / 12	ALA A 416 SER A 415 THR A 497 ILE A 461 PHE A 489	None	1.15A	20.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2w4k	DEATH-ASSOCIATED PROTEIN KINASE 1 (Homo sapiens)	5 / 12	ALA A 25 SER A 21 VAL A 27 ILE A 160 ASN A 144	ADP A1303 ( 3.7A) None ADP A1303 (-4.0A) ADP A1303 ( 4.1A) MG A1304 ( 4.2A)	1.08A	22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	3llr	DNA (CYTOSINE-5)-METHYLT RANSFERASE 3A (Homo sapiens)	6 / 12	ALA A 102 SER A 103 PHE A 80 ILE A 133 ASN A 129 PHE A 76	None	1.49A	18.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	3lrh	ANTI-HUNTINGTIN VL DOMAIN (Homo sapiens)	5 / 12	ALA A 12 SER A 11 VAL A 107 ILE A 20 SER A 73	None	1.25A	15.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	ALA A 18 SER A 19 VAL A 22 GLN A 232 PHE A 366	None	0.74A	99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	7 / 12	ALA A 18 VAL A 22 GLN A 232 PHE A 242 ILE A 263 PHE A 366 HIS A 368	None	1.01A	99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	8 / 12	ALA A 18 VAL A 22 GLN A 232 THR A 240 PHE A 242 ILE A 263 ASN A 264 PHE A 366	None	0.70A	99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	GLN A 232 THR A 240 PHE A 242 ASN A 264 SER A 267	None	0.96A	99.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4cnt	DIHYDROPYRIMIDINASE- LIKE 3 (Homo sapiens)	5 / 12	SER A 385 GLN A 196 THR A 253 ILE A 391 HIS A 73	None	1.25A	19.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4e93	TYROSINE-PROTEIN KINASE FES/FPS (Homo sapiens)	5 / 12	SER A 494 VAL A 495 GLN A 535 THR A 533 HIS A 529	None	1.18A	21.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4gaf	EBI-005 (Homo sapiens)	5 / 12	ALA A 58 SER A 44 PHE A 146 ILE A 10 PHE A 111	None	1.11A	18.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5aul	PHOSPHATIDYLINOSITOL 3-KINASE REGULATORY SUBUNIT ALPHA (Homo sapiens)	5 / 12	SER A 660 VAL A 661 GLN A 705 THR A 701 HIS A 697	None	1.21A	17.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5c6w	PROTEIN IGHV1-69-2,IG LAMBDA CHAIN V-II REGION NIG-84 (Homo sapiens)	5 / 12	ALA H1012 SER H1011 VAL H1107 ILE H1020 SER H1074	None	1.07A	20.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5erd	DESMOGLEIN-2 (Homo sapiens)	5 / 12	SER A 148 GLN A 112 PHE A 115 ILE A 132 PHE A 110	None	1.18A	21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5j0g	OXIDOREDUCTASE,SUPER OXIDE DISMUTASE [CU-ZN] (Homo sapiens)	5 / 12	ALA A 83 SER A 52 VAL A 85 PHE A 63 HIS A 108	None	1.31A	16.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5j5j	DESMOCOLLIN-2,DESMOG LEIN-2 (Homo sapiens)	5 / 12	SER A 146 GLN A 110 PHE A 113 ILE A 130 PHE A 108	None	1.18A	19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_A_HCYA1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5wde	KINESIN-LIKE PROTEIN KIFC3 (Homo sapiens)	5 / 12	SER A 746 VAL A 452 ILE A 479 SER A 489 PHE A 471	None None None UNX A 920 ( 4.4A) None	1.12A	22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	1hfh	FACTOR H, 15TH AND 16TH C-MODULE PAIR (Homo sapiens)	5 / 12	THR A 30 ARG A 20 ILE A 16 ASN A 17 SER A 33	None	1.42A	15.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	1hi2	EOSINOPHIL-DERIVED NEUROTOXIN (Homo sapiens)	5 / 12	THR A 42 ILE A 30 ASN A 31 PHE A 43 HIS A 82	None	1.38A	15.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	1z5v	TUBULIN GAMMA-1 CHAIN (Homo sapiens)	5 / 12	SER A 140 VAL A 171 GLN A 230 ILE A 228 SER A 226	GSP A2466 (-3.1A) None None GSP A2466 (-4.5A) None	1.28A	21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2bo9	HUMAN LATEXIN (Homo sapiens)	5 / 12	VAL B 58 PHE B 89 ILE B 21 ASN B 22 PHE B 91	None	1.38A	18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2nvu	MALTOSE BINDING PROTEIN/NEDD8-ACTIVA TING ENZYME E1 CATALYTIC SUBUNIT CHIMERA NEDD8-CONJUGATING ENZYME UBC12 (Homo sapiens)	5 / 12	SER B2396 PHE C 80 ILE C 125 ASN C 126 PHE C 60	None	1.31A	18.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2r0b	SERINE/THREONINE/TYR OSINE-INTERACTING PROTEIN (Homo sapiens)	5 / 12	THR A 102 PHE A 130 ILE A 95 ASN A 94 PHE A 99	None	1.29A	18.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	3ibj	CGMP-DEPENDENT 3',5'-CYCLIC PHOSPHODIESTERASE (Homo sapiens)	5 / 12	SER A 541 THR A 405 SER A 551 PHE A 404 HIS A 406	None	1.45A	19.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	3wlw	ANTIBODY L CHAIN (Homo sapiens)	5 / 12	SER L 11 VAL L 10 PHE L 64 ILE L 77 HIS L 41	None	1.39A	19.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4a2y	EOSINOPHIL CATIONIC PROTEIN (Homo sapiens)	5 / 12	THR A 42 ILE A 30 ASN A 31 PHE A 43 HIS A 82	None	1.44A	15.50
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	GLN A 232 THR A 240 PHE A 242 ASN A 264 SER A 267	None	0.90A	99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	SER A 19 VAL A 22 GLN A 232 PHE A 242 PHE A 366	None	0.72A	99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	6 / 12	VAL A 22 GLN A 232 PHE A 242 ILE A 263 PHE A 366 HIS A 368	None	1.11A	99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	7 / 12	VAL A 22 GLN A 232 THR A 240 PHE A 242 ILE A 263 ASN A 264 PHE A 366	None	0.72A	99.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5e13	NON-SECRETORY RIBONUCLEASE (Homo sapiens)	5 / 12	THR A 42 ILE A 30 ASN A 31 PHE A 43 HIS A 82	None	1.40A	17.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_B_HCYB1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5nks	DIHYDROPYRIMIDINASE- RELATED PROTEIN 4 (Homo sapiens)	5 / 12	SER A 385 GLN A 196 THR A 253 ILE A 391 HIS A 73	SER A 385 ( 0.0A) GLN A 196 ( 0.6A) THR A 253 ( 0.8A) ILE A 391 ( 0.6A) HIS A 73 ( 1.0A)	1.33A	22.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	1z5v	TUBULIN GAMMA-1 CHAIN (Homo sapiens)	5 / 12	SER A 140 VAL A 171 GLN A 230 ILE A 228 SER A 226	GSP A2466 (-3.1A) None None GSP A2466 (-4.5A) None	1.23A	21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2akz	GAMMA ENOLASE (Homo sapiens)	5 / 12	VAL A 349 GLN A 408 THR A 378 ILE A 133 PHE A 379	None	1.19A	22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2bo9	HUMAN LATEXIN (Homo sapiens)	5 / 12	VAL B 58 PHE B 89 ILE B 21 ASN B 22 PHE B 91	None	1.35A	18.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2fv5	ADAM 17 (Homo sapiens)	5 / 12	VAL A 364 THR A 404 ILE A 458 SER A 454 HIS A 405	None None None None ZN A 3 ( 3.2A)	1.26A	22.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2nvu	MALTOSE BINDING PROTEIN/NEDD8-ACTIVA TING ENZYME E1 CATALYTIC SUBUNIT CHIMERA NEDD8-CONJUGATING ENZYME UBC12 (Homo sapiens)	5 / 12	SER B2396 PHE C 80 ILE C 125 ASN C 126 PHE C 60	None	1.33A	18.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2pg6	CYTOCHROME P450 2A6 (Homo sapiens)	5 / 12	SER A 175 THR A 212 PHE A 107 ILE A 300 PHE A 209	None	1.47A	21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2r0b	SERINE/THREONINE/TYR OSINE-INTERACTING PROTEIN (Homo sapiens)	5 / 12	THR A 102 PHE A 130 ILE A 95 ASN A 94 PHE A 99	None	1.24A	18.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	3llr	DNA (CYTOSINE-5)-METHYLT RANSFERASE 3A (Homo sapiens)	5 / 12	SER A 103 PHE A 80 ILE A 133 ASN A 129 PHE A 76	None	1.44A	18.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	3u1k	POLYRIBONUCLEOTIDE NUCLEOTIDYLTRANSFERA SE 1, MITOCHONDRIAL (Homo sapiens)	5 / 12	VAL A 313 THR A 287 ASN A 540 PHE A 340 HIS A 288	None	1.42A	21.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	3vvw	CALCIUM-BINDING AND COILED-COIL DOMAIN-CONTAINING PROTEIN 2 (Homo sapiens)	5 / 12	VAL A 23 PHE A 107 ILE A 56 PHE A 25 HIS A 41	None	1.20A	14.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	GLN A 232 THR A 240 PHE A 242 ASN A 264 SER A 267	None	0.84A	99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	THR A 240 PHE A 242 ASN A 264 SER A 267 HIS A 368	None	1.03A	99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	7 / 12	VAL A 22 GLN A 232 THR A 240 PHE A 242 ILE A 263 ASN A 264 PHE A 366	None	0.67A	99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	6 / 12	VAL A 22 THR A 240 PHE A 242 ASN A 264 PHE A 366 HIS A 368	None	0.82A	99.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5d2n	C25 BETA (Homo sapiens)	5 / 12	SER F 7 GLN F 54 THR F 47 PHE F 49 ARG F 22	None	1.01A	23.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5erd	DESMOGLEIN-2 (Homo sapiens)	5 / 12	SER A 148 GLN A 112 PHE A 115 ILE A 132 PHE A 110	None	1.32A	21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5hx6	RECEPTOR-INTERACTING SERINE/THREONINE-PRO TEIN KINASE 1 (Homo sapiens)	5 / 12	SER A 73 PHE A 278 ARG A 74 ILE A 123 HIS A 136	None None None None 65U A 301 (-3.3A)	1.46A	21.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5j5j	DESMOCOLLIN-2,DESMOG LEIN-2 (Homo sapiens)	5 / 12	SER A 146 GLN A 110 PHE A 113 ILE A 130 PHE A 108	None	1.35A	19.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5u03	CTP SYNTHASE 1 (Homo sapiens)	5 / 12	SER A 22 VAL A 23 GLN A 240 ILE A 178 PHE A 266	None	1.44A	19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_C_HCYC1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5wde	KINESIN-LIKE PROTEIN KIFC3 (Homo sapiens)	5 / 12	SER A 746 VAL A 452 ILE A 479 SER A 489 PHE A 471	None None None UNX A 920 ( 4.4A) None	1.38A	22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_D_HCYD1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	1itu	RENAL DIPEPTIDASE (Homo sapiens)	5 / 12	THR A 149 ARG A 229 ASN A 231 HIS A 152 TRP A 162	None None None CIL A 451 (-4.0A) None	1.31A	22.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_D_HCYD1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	1lhu	SEX HORMONE-BINDING GLOBULIN (Homo sapiens)	5 / 12	SER A 111 VAL A 112 ILE A 78 PHE A 67 HIS A 81	None None None EST A 301 (-4.0A) None	1.11A	18.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_D_HCYD1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	1z5v	TUBULIN GAMMA-1 CHAIN (Homo sapiens)	5 / 12	SER A 140 VAL A 171 GLN A 230 ILE A 228 SER A 226	GSP A2466 (-3.1A) None None GSP A2466 (-4.5A) None	1.30A	21.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_D_HCYD1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2akz	GAMMA ENOLASE (Homo sapiens)	5 / 12	VAL A 349 GLN A 408 THR A 378 ILE A 133 PHE A 379	None	1.22A	22.03
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_D_HCYD1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	2nvu	MALTOSE BINDING PROTEIN/NEDD8-ACTIVA TING ENZYME E1 CATALYTIC SUBUNIT CHIMERA NEDD8-CONJUGATING ENZYME UBC12 (Homo sapiens)	5 / 12	SER B2396 PHE C 80 ILE C 125 ASN C 126 PHE C 60	None	1.39A	18.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_D_HCYD1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	3lmk	METABOTROPIC GLUTAMATE RECEPTOR 5 (Homo sapiens)	5 / 12	SER A 215 VAL A 214 GLN A 198 SER A 304 PHE A 231	None	1.32A	21.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_D_HCYD1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	3u1k	POLYRIBONUCLEOTIDE NUCLEOTIDYLTRANSFERA SE 1, MITOCHONDRIAL (Homo sapiens)	5 / 12	VAL A 313 THR A 287 ASN A 540 PHE A 340 HIS A 288	None	1.42A	21.95
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_D_HCYD1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	6 / 12	GLN A 232 THR A 240 PHE A 242 ASN A 264 SER A 267 PHE A 366	None	0.69A	99.46
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4C49_D_HCYD1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	7 / 12	VAL A 22 GLN A 232 THR A 240 PHE A 242 ILE A 263 ASN A 264 PHE A 366	None	0.71A	99.46
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_D_HCYD1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4fdj	N-ACETYLGALACTOSAMIN E-6-SULFATASE (Homo sapiens)	5 / 12	VAL A 277 PHE A 216 ILE A 217 PHE A 226 HIS A 224	None	1.41A	20.70
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_D_HCYD1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4kmh	SUPPRESSOR OF FUSED HOMOLOG (Homo sapiens)	5 / 12	SER A 377 GLN A 432 ILE A 406 PHE A 408 HIS A 394	None	1.29A	21.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_D_HCYD1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	4xib	E3 UBIQUITIN-PROTEIN LIGASE MIB1 (Homo sapiens)	5 / 12	VAL A 19 ARG A 20 ILE A 146 PHE A 226 HIS A 230	None	1.39A	21.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_D_HCYD1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5k10	ISOCITRATE DEHYDROGENASE [NADP] CYTOPLASMIC (Homo sapiens)	5 / 12	THR A 325 PHE A 395 ARG A 20 ILE A 21 HIS A 315	None None None None NDP A 501 (-4.7A)	1.46A	19.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_D_HCYD1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5nug	CYTOPLASMIC DYNEIN 1 HEAVY CHAIN 1 (Homo sapiens)	5 / 12	VAL A2592 ILE A2666 ASN A2667 PHE A2727 HIS A2725	None	1.27A	5.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_D_HCYD1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5u03	CTP SYNTHASE 1 (Homo sapiens)	5 / 12	SER A 22 VAL A 23 GLN A 240 ILE A 178 PHE A 266	None	1.44A	19.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4C49_D_HCYD1384_1 (CORTICOSTEROID-BINDI NG GLOBULIN)	5wde	KINESIN-LIKE PROTEIN KIFC3 (Homo sapiens)	5 / 12	SER A 746 VAL A 452 ILE A 479 SER A 489 PHE A 471	None None None UNX A 920 ( 4.4A) None	1.34A	22.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	1ufw	SYNAPTOJANIN 2 (Homo sapiens)	5 / 12	MET A 42 LEU A 41 LEU A 22 ILE A 51 PHE A 65	None	1.35A	17.19
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	LEU A 704 ASN A 705 GLY A 708 GLN A 711 MET A 742 ARG A 752	BHM A 1 (-4.0A) BHM A 1 (-3.6A) BHM A 1 ( 3.8A) BHM A 1 (-2.2A) BHM A 1 ( 4.0A) BHM A 1 (-3.8A)	0.94A	49.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	LEU A 704 ASN A 705 GLY A 708 GLN A 711 MET A 742 PHE A 891	BHM A 1 (-4.0A) BHM A 1 (-3.6A) BHM A 1 ( 3.8A) BHM A 1 (-2.2A) BHM A 1 ( 4.0A) None	0.93A	49.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	5 / 12	LEU A 704 GLN A 711 MET A 742 ARG A 752 GLN A 783	BHM A 1 (-4.0A) BHM A 1 (-2.2A) BHM A 1 ( 4.0A) BHM A 1 (-3.8A) None	1.35A	49.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	2g76	D-3-PHOSPHOGLYCERATE DEHYDROGENASE (Homo sapiens)	5 / 12	LEU A 216 ASN A 217 GLY A 214 LEU A 150 GLN A 223	None	1.36A	21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	2z5x	AMINE OXIDASE [FLAVIN-CONTAINING] A (Homo sapiens)	5 / 12	GLY A 22 MET A 445 LEU A 80 GLN A 225 THR A 54	FAD A 600 (-3.2A) FAD A 600 (-4.3A) None None None	1.44A	20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	3f81	DUAL SPECIFICITY PROTEIN PHOSPHATASE 3 (Homo sapiens)	5 / 12	LEU A 177 ARG A 176 GLN A 143 THR A 34 ILE A 37	None	1.48A	21.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	5 / 12	GLY A 722 GLN A 725 MET A 756 LEU A 763 ARG A 766	WOW A 1 ( 4.3A) WOW A 1 ( 4.1A) WOW A 1 ( 4.1A) WOW A 1 ( 4.0A) WOW A 1 (-3.8A)	0.85A	54.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	8 / 12	LEU A 718 ASN A 719 GLY A 722 MET A 756 LEU A 763 ARG A 766 THR A 894 PHE A 905	WOW A 1 (-4.2A) WOW A 1 (-3.3A) WOW A 1 ( 4.3A) WOW A 1 ( 4.1A) WOW A 1 ( 4.0A) WOW A 1 (-3.8A) WOW A 1 (-3.9A) WOW A 1 (-4.6A)	0.75A	54.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	4cak	INTEGRIN ALPHA-IIB INTEGRIN BETA-3 (Homo sapiens)	5 / 12	GLY B 293 LEU B 246 ARG A 317 GLN B 228 THR A 413	None	1.35A	16.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	ASN A 564 GLY A 567 LEU A 627 THR A 739 PHE A 749	MOF A 801 (-3.0A) MOF A 801 (-3.4A) None MOF A 801 (-3.9A) MOF A 801 (-4.4A)	1.44A	98.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	ASN A 564 GLY A 568 MET A 601 ILE A 747 PHE A 749	MOF A 801 (-3.0A) None MOF A 801 (-3.7A) MOF A 801 ( 4.4A) MOF A 801 (-4.4A)	0.90A	98.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	11 / 12	MET A 560 LEU A 563 ASN A 564 GLY A 567 GLN A 570 MET A 601 LEU A 608 ARG A 611 THR A 739 ILE A 747 PHE A 749	MOF A 801 (-3.9A) MOF A 801 (-3.9A) MOF A 801 (-3.0A) MOF A 801 (-3.4A) MOF A 801 (-2.9A) MOF A 801 (-3.7A) MOF A 801 ( 4.6A) MOF A 801 (-4.2A) MOF A 801 (-3.9A) MOF A 801 ( 4.4A) MOF A 801 (-4.4A)	0.52A	98.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	MET A 560 LEU A 563 LEU A 621 THR A 739 ILE A 747	MOF A 801 (-3.9A) MOF A 801 (-3.9A) None MOF A 801 (-3.9A) MOF A 801 ( 4.4A)	1.25A	98.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	4u8d	SORCIN (Homo sapiens)	5 / 12	LEU A 58 GLY A 62 LEU A 35 ILE A 160 PHE A 156	None	1.24A	20.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	8 / 12	LEU A 769 ASN A 770 GLN A 776 MET A 807 LEU A 814 ARG A 817 THR A 945 PHE A 956	CV7 A1987 (-4.1A) CV7 A1987 (-3.1A) CV7 A1987 (-3.0A) CV7 A1987 ( 3.9A) CV7 A1987 ( 4.0A) CV7 A1987 (-3.7A) CV7 A1987 (-3.1A) CV7 A1987 ( 4.7A)	0.47A	54.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	ASN A 770 GLY A 774 GLN A 776 THR A 945 PHE A 956	ECV A1101 (-3.1A) None ECV A1101 (-2.9A) ECV A1101 (-3.2A) ECV A1101 ( 4.7A)	1.24A	45.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	8 / 12	LEU A 769 ASN A 770 GLN A 776 MET A 807 LEU A 814 ARG A 817 THR A 945 PHE A 956	ECV A1101 (-4.7A) ECV A1101 (-3.1A) ECV A1101 (-2.9A) ECV A1101 (-3.6A) ECV A1101 (-4.1A) ECV A1101 (-4.0A) ECV A1101 (-3.2A) ECV A1101 ( 4.7A)	0.56A	45.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	5n6c	D-3-PHOSPHOGLYCERATE DEHYDROGENASE (Homo sapiens)	5 / 12	LEU A 217 ASN A 218 GLY A 215 LEU A 151 GLN A 224	None	1.39A	16.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	5nzp	D-3-PHOSPHOGLYCERATE DEHYDROGENASE (Homo sapiens)	5 / 12	LEU B 217 ASN B 218 GLY B 215 LEU B 151 GLN B 224	None None None 9EW B 301 ( 4.8A) None	1.25A	22.14
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	5toa	ESTROGEN RECEPTOR BETA (Homo sapiens)	5 / 12	MET A 295 LEU A 298 MET A 336 LEU A 343 ARG A 346	EST A 601 ( 4.4A) EST A 601 (-4.1A) EST A 601 ( 3.7A) EST A 601 ( 4.4A) EST A 601 (-4.1A)	0.98A	30.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_A_HCYA900_1 (GLUCOCORTICOID RECEPTOR)	6au8	GOLGI TO ER TRAFFIC PROTEIN 4 HOMOLOG LARGE PROLINE-RICH PROTEIN BAG6 (Homo sapiens)	5 / 12	GLN C1023 LEU A 266 THR A 220 ILE A 226 PHE A 232	None	1.43A	13.86
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_C_HCYC900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	5 / 11	ASN A 705 LEU A 707 GLN A 711 MET A 742 ARG A 752	BHM A 1 (-3.6A) BHM A 1 ( 4.2A) BHM A 1 (-2.2A) BHM A 1 ( 4.0A) BHM A 1 (-3.8A)	0.75A	49.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_C_HCYC900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	5 / 11	ASN A 705 LEU A 707 GLN A 711 MET A 745 ARG A 752	BHM A 1 (-3.6A) BHM A 1 ( 4.2A) BHM A 1 (-2.2A) BHM A 1 (-3.9A) BHM A 1 (-3.8A)	1.02A	49.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_C_HCYC900_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	5 / 11	ASN A 719 LEU A 721 MET A 756 ARG A 766 THR A 894	WOW A 1 (-3.3A) WOW A 1 ( 4.3A) WOW A 1 ( 4.1A) WOW A 1 (-3.8A) WOW A 1 (-3.9A)	0.73A	54.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_C_HCYC900_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	10 / 11	MET A 560 ASN A 564 LEU A 566 GLN A 570 TRP A 600 MET A 601 MET A 604 ARG A 611 THR A 739 ILE A 747	MOF A 801 (-3.9A) MOF A 801 (-3.0A) MOF A 801 ( 4.6A) MOF A 801 (-2.9A) None MOF A 801 (-3.7A) None MOF A 801 (-4.2A) MOF A 801 (-3.9A) MOF A 801 ( 4.4A)	0.41A	98.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_C_HCYC900_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 11	ASN A 770 LEU A 772 GLN A 776 TRP A 806 MET A 807 ARG A 817 THR A 945	CV7 A1987 (-3.1A) CV7 A1987 ( 4.5A) CV7 A1987 (-3.0A) None CV7 A1987 ( 3.9A) CV7 A1987 (-3.7A) CV7 A1987 (-3.1A)	0.39A	54.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_C_HCYC900_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 11	ASN A 770 LEU A 772 GLN A 776 TRP A 806 MET A 807 ARG A 817 THR A 945	ECV A1101 (-3.1A) ECV A1101 ( 3.9A) ECV A1101 (-2.9A) None ECV A1101 (-3.6A) ECV A1101 (-4.0A) ECV A1101 (-3.2A)	0.41A	45.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_C_HCYC900_1 (GLUCOCORTICOID RECEPTOR)	5toa	ESTROGEN RECEPTOR BETA (Homo sapiens)	5 / 11	MET A 295 LEU A 301 TRP A 335 MET A 336 ARG A 346	EST A 601 ( 4.4A) EST A 601 ( 4.3A) None EST A 601 ( 3.7A) EST A 601 (-4.1A)	0.75A	30.11
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	7 / 12	LEU A 704 ASN A 705 GLY A 708 GLN A 711 MET A 742 ARG A 752 PHE A 891	BHM A 1 (-4.0A) BHM A 1 (-3.6A) BHM A 1 ( 3.8A) BHM A 1 (-2.2A) BHM A 1 ( 4.0A) BHM A 1 (-3.8A) None	0.96A	49.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	LEU A 704 ASN A 705 GLY A 708 GLN A 711 MET A 745 ARG A 752	BHM A 1 (-4.0A) BHM A 1 (-3.6A) BHM A 1 ( 3.8A) BHM A 1 (-2.2A) BHM A 1 (-3.9A) BHM A 1 (-3.8A)	1.02A	49.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	5 / 12	LEU A 704 GLN A 711 MET A 742 ARG A 752 GLN A 783	BHM A 1 (-4.0A) BHM A 1 (-2.2A) BHM A 1 ( 4.0A) BHM A 1 (-3.8A) None	1.38A	49.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	5 / 12	LEU A 704 GLN A 711 MET A 745 ARG A 752 GLN A 783	BHM A 1 (-4.0A) BHM A 1 (-2.2A) BHM A 1 (-3.9A) BHM A 1 (-3.8A) None	1.37A	49.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	2g76	D-3-PHOSPHOGLYCERATE DEHYDROGENASE (Homo sapiens)	5 / 12	LEU A 216 ASN A 217 GLY A 214 LEU A 150 GLN A 223	None	1.39A	21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	3f81	DUAL SPECIFICITY PROTEIN PHOSPHATASE 3 (Homo sapiens)	5 / 12	LEU A 177 ARG A 176 GLN A 143 THR A 34 ILE A 37	None	1.47A	21.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	5 / 12	GLY A 722 GLN A 725 MET A 756 MET A 759 ARG A 766	WOW A 1 ( 4.3A) WOW A 1 ( 4.1A) WOW A 1 ( 4.1A) WOW A 1 (-3.7A) WOW A 1 (-3.8A)	1.23A	54.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	6 / 12	GLY A 722 MET A 756 MET A 759 LEU A 763 ARG A 766 PHE A 905	WOW A 1 ( 4.3A) WOW A 1 ( 4.1A) WOW A 1 (-3.7A) WOW A 1 ( 4.0A) WOW A 1 (-3.8A) WOW A 1 (-4.6A)	0.94A	54.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	8 / 12	LEU A 718 ASN A 719 GLY A 722 MET A 756 LEU A 763 ARG A 766 THR A 894 PHE A 905	WOW A 1 (-4.2A) WOW A 1 (-3.3A) WOW A 1 ( 4.3A) WOW A 1 ( 4.1A) WOW A 1 ( 4.0A) WOW A 1 (-3.8A) WOW A 1 (-3.9A) WOW A 1 (-4.6A)	0.69A	54.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	4cak	INTEGRIN ALPHA-IIB INTEGRIN BETA-3 (Homo sapiens)	5 / 12	GLY B 293 LEU B 246 ARG A 317 GLN B 228 THR A 413	None	1.34A	16.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	ASN A 564 GLY A 567 LEU A 627 THR A 739 PHE A 749	MOF A 801 (-3.0A) MOF A 801 (-3.4A) None MOF A 801 (-3.9A) MOF A 801 (-4.4A)	1.44A	98.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	ASN A 564 GLY A 568 MET A 601 THR A 739 ILE A 747 PHE A 749	MOF A 801 (-3.0A) None MOF A 801 (-3.7A) MOF A 801 (-3.9A) MOF A 801 ( 4.4A) MOF A 801 (-4.4A)	0.97A	98.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	11 / 12	LEU A 563 ASN A 564 GLY A 567 GLN A 570 MET A 601 MET A 604 LEU A 608 ARG A 611 THR A 739 ILE A 747 PHE A 749	MOF A 801 (-3.9A) MOF A 801 (-3.0A) MOF A 801 (-3.4A) MOF A 801 (-2.9A) MOF A 801 (-3.7A) None MOF A 801 ( 4.6A) MOF A 801 (-4.2A) MOF A 801 (-3.9A) MOF A 801 ( 4.4A) MOF A 801 (-4.4A)	0.39A	98.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	LEU A 563 LEU A 621 THR A 739 ILE A 747 PHE A 749	MOF A 801 (-3.9A) None MOF A 801 (-3.9A) MOF A 801 ( 4.4A) MOF A 801 (-4.4A)	1.46A	98.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	4u8d	SORCIN (Homo sapiens)	5 / 12	LEU A 58 GLY A 62 LEU A 35 ILE A 160 PHE A 156	None	1.29A	20.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	8 / 12	LEU A 769 ASN A 770 GLN A 776 MET A 807 LEU A 814 ARG A 817 THR A 945 PHE A 956	CV7 A1987 (-4.1A) CV7 A1987 (-3.1A) CV7 A1987 (-3.0A) CV7 A1987 ( 3.9A) CV7 A1987 ( 4.0A) CV7 A1987 (-3.7A) CV7 A1987 (-3.1A) CV7 A1987 ( 4.7A)	0.38A	54.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	4xny	HEAVY CHAIN OF ANTIBODY VRC08C LIGHT CHAIN OF ANTIBODY VRC08C (Homo sapiens)	5 / 12	ASN H 35 GLN L 89 LEU L 46 GLN H 4 ILE H 34	None	1.40A	19.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	5fu7	CCR4-NOT TRANSCRIPTION COMPLEX SUBUNIT 1 (Homo sapiens)	5 / 12	LEU A1967 ASN A1964 GLY A1968 LEU A2026 ILE A1960	None	1.35A	19.92
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	8 / 12	LEU A 769 ASN A 770 GLN A 776 MET A 807 LEU A 814 ARG A 817 THR A 945 PHE A 956	ECV A1101 (-4.7A) ECV A1101 (-3.1A) ECV A1101 (-2.9A) ECV A1101 (-3.6A) ECV A1101 (-4.1A) ECV A1101 (-4.0A) ECV A1101 (-3.2A) ECV A1101 ( 4.7A)	0.49A	45.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	5n6c	D-3-PHOSPHOGLYCERATE DEHYDROGENASE (Homo sapiens)	5 / 12	LEU A 217 ASN A 218 GLY A 215 LEU A 151 GLN A 224	None	1.41A	16.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	5nzp	D-3-PHOSPHOGLYCERATE DEHYDROGENASE (Homo sapiens)	5 / 12	LEU B 217 ASN B 218 GLY B 215 LEU B 151 GLN B 224	None None None 9EW B 301 ( 4.8A) None	1.29A	22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_E_HCYE900_1 (GLUCOCORTICOID RECEPTOR)	6au8	GOLGI TO ER TRAFFIC PROTEIN 4 HOMOLOG LARGE PROLINE-RICH PROTEIN BAG6 (Homo sapiens)	5 / 12	GLN C1023 LEU A 266 THR A 220 ILE A 226 PHE A 232	None	1.46A	13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	1nxk	MAP KINASE-ACTIVATED PROTEIN KINASE 2 (Homo sapiens)	5 / 12	TRP A 324 LEU A 249 THR A 338 ILE A 150 PHE A 158	None	1.43A	20.63
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	ASN A 705 GLY A 708 GLN A 711 MET A 742 ARG A 752 PHE A 891	BHM A 1 (-3.6A) BHM A 1 ( 3.8A) BHM A 1 (-2.2A) BHM A 1 ( 4.0A) BHM A 1 (-3.8A) None	0.86A	49.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	5 / 12	GLY A 708 GLN A 711 MET A 742 ARG A 752 MET A 787	BHM A 1 ( 3.8A) BHM A 1 (-2.2A) BHM A 1 ( 4.0A) BHM A 1 (-3.8A) BHM A 1 (-3.6A)	0.93A	49.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	2rgz	HEME OXYGENASE 2 (Homo sapiens)	5 / 12	MET A 158 LEU A 97 MET A 206 THR A 41 PHE A 227	None None None None HEM A 300 (-4.1A)	1.46A	22.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	3f81	DUAL SPECIFICITY PROTEIN PHOSPHATASE 3 (Homo sapiens)	5 / 12	LEU A 177 ARG A 176 GLN A 143 THR A 34 ILE A 37	None	1.49A	21.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	5 / 12	ASN A 719 GLY A 722 LEU A 782 THR A 894 PHE A 905	WOW A 1 (-3.3A) WOW A 1 ( 4.3A) None WOW A 1 (-3.9A) WOW A 1 (-4.6A)	1.49A	54.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	8 / 12	ASN A 719 GLY A 722 MET A 756 LEU A 763 ARG A 766 MET A 801 THR A 894 PHE A 905	WOW A 1 (-3.3A) WOW A 1 ( 4.3A) WOW A 1 ( 4.1A) WOW A 1 ( 4.0A) WOW A 1 (-3.8A) WOW A 1 (-4.2A) WOW A 1 (-3.9A) WOW A 1 (-4.6A)	0.81A	54.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	7 / 12	ASN A 719 TRP A 755 MET A 756 LEU A 763 MET A 801 THR A 894 PHE A 905	WOW A 1 (-3.3A) None WOW A 1 ( 4.1A) WOW A 1 ( 4.0A) WOW A 1 (-4.2A) WOW A 1 (-3.9A) WOW A 1 (-4.6A)	1.16A	54.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	6 / 12	GLY A 722 GLN A 725 MET A 756 LEU A 763 ARG A 766 MET A 801	WOW A 1 ( 4.3A) WOW A 1 ( 4.1A) WOW A 1 ( 4.1A) WOW A 1 ( 4.0A) WOW A 1 (-3.8A) WOW A 1 (-4.2A)	0.90A	54.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	3kn5	RIBOSOMAL PROTEIN S6 KINASE ALPHA-5 (Homo sapiens)	5 / 12	TRP A 686 LEU A 608 THR A 700 ILE A 510 PHE A 516	None	1.40A	22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	4cak	INTEGRIN ALPHA-IIB INTEGRIN BETA-3 (Homo sapiens)	5 / 12	GLY B 293 LEU B 246 ARG A 317 GLN B 228 THR A 413	None	1.34A	16.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	11 / 12	ASN A 564 GLY A 567 GLN A 570 TRP A 600 MET A 601 LEU A 608 ARG A 611 MET A 646 THR A 739 ILE A 747 PHE A 749	MOF A 801 (-3.0A) MOF A 801 (-3.4A) MOF A 801 (-2.9A) None MOF A 801 (-3.7A) MOF A 801 ( 4.6A) MOF A 801 (-4.2A) MOF A 801 (-4.4A) MOF A 801 (-3.9A) MOF A 801 ( 4.4A) MOF A 801 (-4.4A)	0.42A	98.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	ASN A 564 GLY A 567 LEU A 627 THR A 739 PHE A 749	MOF A 801 (-3.0A) MOF A 801 (-3.4A) None MOF A 801 (-3.9A) MOF A 801 (-4.4A)	1.42A	98.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	ASN A 564 GLY A 568 TRP A 600 MET A 601 THR A 739 ILE A 747 PHE A 749	MOF A 801 (-3.0A) None None MOF A 801 (-3.7A) MOF A 801 (-3.9A) MOF A 801 ( 4.4A) MOF A 801 (-4.4A)	0.94A	98.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	MET A 601 LEU A 608 ARG A 611 GLN A 642 MET A 646	MOF A 801 (-3.7A) MOF A 801 ( 4.6A) MOF A 801 (-4.2A) None MOF A 801 (-4.4A)	0.92A	98.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	8 / 12	ASN A 770 GLN A 776 TRP A 806 MET A 807 LEU A 814 ARG A 817 MET A 852 THR A 945	CV7 A1987 (-3.1A) CV7 A1987 (-3.0A) None CV7 A1987 ( 3.9A) CV7 A1987 ( 4.0A) CV7 A1987 (-3.7A) CV7 A1987 ( 3.7A) CV7 A1987 (-3.1A)	0.66A	54.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	8 / 12	ASN A 770 GLN A 776 TRP A 806 MET A 807 LEU A 814 ARG A 817 THR A 945 PHE A 956	CV7 A1987 (-3.1A) CV7 A1987 (-3.0A) None CV7 A1987 ( 3.9A) CV7 A1987 ( 4.0A) CV7 A1987 (-3.7A) CV7 A1987 (-3.1A) CV7 A1987 ( 4.7A)	0.36A	54.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	ASN A 770 GLY A 774 TRP A 806 THR A 945 PHE A 956	CV7 A1987 (-3.1A) None None CV7 A1987 (-3.1A) CV7 A1987 ( 4.7A)	1.09A	54.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	5bo6	SIA-ALPHA-2,3-GAL-BE TA-1,4-GLCNAC-R:ALPH A 2,8-SIALYLTRANSFERAS E (Homo sapiens)	5 / 12	GLY A 302 LEU A 299 GLN A 100 THR A 372 ILE A 316	CDP A 411 (-3.3A) None None None None	1.37A	21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	5m23	WD REPEAT-CONTAINING PROTEIN 5 (Homo sapiens)	5 / 12	GLY A 183 GLN A 140 LEU A 143 ILE A 197 PHE A 222	None	1.50A	20.59
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	8 / 12	ASN A 770 GLN A 776 TRP A 806 MET A 807 LEU A 814 ARG A 817 THR A 945 PHE A 956	ECV A1101 (-3.1A) ECV A1101 (-2.9A) None ECV A1101 (-3.6A) ECV A1101 (-4.1A) ECV A1101 (-4.0A) ECV A1101 (-3.2A) ECV A1101 ( 4.7A)	0.48A	45.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	ASN A 770 GLY A 774 TRP A 806 THR A 945 PHE A 956	ECV A1101 (-3.1A) None None ECV A1101 (-3.2A) ECV A1101 ( 4.7A)	1.02A	45.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	6 / 12	GLN A 776 TRP A 806 MET A 807 LEU A 814 ARG A 817 MET A 852	ECV A1101 (-2.9A) None ECV A1101 (-3.6A) ECV A1101 (-4.1A) ECV A1101 (-4.0A) ECV A1101 (-3.7A)	1.22A	45.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	5yh3	EXTRACELLULAR SERINE/THREONINE PROTEIN KINASE FAM20C (Homo sapiens)	5 / 12	ASN C 479 GLY C 482 LEU C 546 ARG C 549 MET C 525	None	1.47A	13.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_1 (GLUCOCORTICOID RECEPTOR)	6au8	GOLGI TO ER TRAFFIC PROTEIN 4 HOMOLOG LARGE PROLINE-RICH PROTEIN BAG6 (Homo sapiens)	5 / 12	GLN C1023 LEU A 266 THR A 220 ILE A 226 PHE A 232	None	1.47A	13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_2 (GLUCOCORTICOID RECEPTOR)	1bhg	BETA-GLUCURONIDASE (Homo sapiens)	3 / 3	LEU A 322 MET A 393 TYR A 301	None	0.70A	16.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_2 (GLUCOCORTICOID RECEPTOR)	1hkk	CHITOTRIOSIDASE-1 (Homo sapiens)	3 / 3	LEU A 360 MET A 356 TYR A 303	None AMI A1388 (-4.0A) None	0.96A	20.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_2 (GLUCOCORTICOID RECEPTOR)	1x9q	4M5.3 ANTI-FLUORESCEIN SINGLE CHAIN ANTIBODY FRAGMENT (Homo sapiens)	3 / 3	LEU A 259 MET A 185 TYR A 247	None	0.75A	18.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_2 (GLUCOCORTICOID RECEPTOR)	2ch6	N-ACETYL-D-GLUCOSAMI NE KINASE (Homo sapiens)	3 / 3	LEU A 264 MET A 305 TYR A 341	None	0.77A	19.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_2 (GLUCOCORTICOID RECEPTOR)	2f5a	PROTEIN (ANTIBODY 2F5 (HEAVY CHAIN)) PROTEIN (ANTIBODY 2F5 (LIGHT CHAIN)) (Homo sapiens)	3 / 3	LEU H 47 MET H 119 TYR L 86	None	0.95A	20.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_2 (GLUCOCORTICOID RECEPTOR)	2i6t	UBIQUITIN-CONJUGATIN G ENZYME E2-LIKE ISOFORM A (Homo sapiens)	3 / 3	LEU A 321 MET A 397 TYR A 328	GOL A 6 (-3.8A) None None	0.85A	22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_2 (GLUCOCORTICOID RECEPTOR)	3a62	RIBOSOMAL PROTEIN S6 KINASE BETA-1 (Homo sapiens)	3 / 3	LEU A 168 MET A 122 TYR A 102	None	0.90A	20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_2 (GLUCOCORTICOID RECEPTOR)	3q13	SPONDIN-1 (Homo sapiens)	3 / 3	LEU A 350 MET A 320 TYR A 212	None None NAG A 502 ( 3.8A)	0.93A	21.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_2 (GLUCOCORTICOID RECEPTOR)	4hjj	ANTI-IL12 ANTI-IL18 DFAB HEAVY CHAIN ANTI-IL12 ANTI-IL18 DFAB LIGHT CHAIN (Homo sapiens)	3 / 3	LEU H 47 MET H 106 TYR L 86	None	0.96A	20.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_2 (GLUCOCORTICOID RECEPTOR)	5gje	LOW-DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN 6 (Homo sapiens)	3 / 3	LEU B 873 MET B 877 TYR B 846	None	0.81A	17.98
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_2 (GLUCOCORTICOID RECEPTOR)	5knm	CDNA FLJ39643 FIS, CLONE SMINT2004023, HIGHLY SIMILAR TO HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, ALPHACHAIN F (Homo sapiens)	3 / 3	LEU A 5 MET A 98 TYR A 159	None	0.73A	22.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_2 (GLUCOCORTICOID RECEPTOR)	5nr4	CLIP-ASSOCIATING PROTEIN 2 (Homo sapiens)	3 / 3	LEU A 97 MET A 120 TYR A 89	None	0.88A	14.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_2 (GLUCOCORTICOID RECEPTOR)	5nr4	CLIP-ASSOCIATING PROTEIN 2 (Homo sapiens)	3 / 3	LEU A 115 MET A 120 TYR A 89	None	0.85A	14.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_2 (GLUCOCORTICOID RECEPTOR)	5whr	INDOLEAMINE 2,3-DIOXYGENASE 1 (Homo sapiens)	3 / 3	LEU A 83 MET A 40 TYR A 90	None	0.84A	18.18
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_2 (GLUCOCORTICOID RECEPTOR)	6bqh	5-HYDROXYTRYPTAMINE RECEPTOR 2C,SOLUBLE CYTOCHROME B562 (Escherichia coli; Homo sapiens)	3 / 3	LEU A 227 MET A 143 TYR A 234	None OLC A1207 ( 3.9A) None	0.51A	16.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_G_HCYG900_2 (GLUCOCORTICOID RECEPTOR)	6cmj	CALCIUM/CALMODULIN-D EPENDENT PROTEIN KINASE KINASE 2 (Homo sapiens)	3 / 3	LEU A 263 MET A 193 TYR A 176	None	0.68A	13.36
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	5 / 12	GLN A 711 MET A 742 ARG A 752 GLN A 783 MET A 787	BHM A 1 (-2.2A) BHM A 1 ( 4.0A) BHM A 1 (-3.8A) None BHM A 1 (-3.6A)	1.22A	49.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	5 / 12	GLY A 708 GLN A 711 MET A 742 ARG A 752 MET A 787	BHM A 1 ( 3.8A) BHM A 1 (-2.2A) BHM A 1 ( 4.0A) BHM A 1 (-3.8A) BHM A 1 (-3.6A)	0.93A	49.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	LEU A 704 ASN A 705 GLY A 708 GLN A 711 MET A 742 ARG A 752	BHM A 1 (-4.0A) BHM A 1 (-3.6A) BHM A 1 ( 3.8A) BHM A 1 (-2.2A) BHM A 1 ( 4.0A) BHM A 1 (-3.8A)	0.87A	49.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	LEU A 704 ASN A 705 GLY A 708 GLN A 711 MET A 742 PHE A 891	BHM A 1 (-4.0A) BHM A 1 (-3.6A) BHM A 1 ( 3.8A) BHM A 1 (-2.2A) BHM A 1 ( 4.0A) None	0.92A	49.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	5 / 12	LEU A 704 GLN A 711 MET A 742 ARG A 752 GLN A 783	BHM A 1 (-4.0A) BHM A 1 (-2.2A) BHM A 1 ( 4.0A) BHM A 1 (-3.8A) None	1.36A	49.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	2g76	D-3-PHOSPHOGLYCERATE DEHYDROGENASE (Homo sapiens)	5 / 12	LEU A 216 ASN A 217 GLY A 214 LEU A 150 GLN A 223	None	1.40A	21.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	2rgz	HEME OXYGENASE 2 (Homo sapiens)	5 / 12	MET A 158 LEU A 97 MET A 206 THR A 41 PHE A 227	None None None None HEM A 300 (-4.1A)	1.47A	22.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	3d5f	PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR DELTA (Homo sapiens)	5 / 12	LEU A 417 LEU A 436 MET A 439 ILE A 218 PHE A 214	None	1.31A	21.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	3f81	DUAL SPECIFICITY PROTEIN PHOSPHATASE 3 (Homo sapiens)	5 / 12	LEU A 177 ARG A 176 GLN A 143 THR A 34 ILE A 37	None	1.44A	21.24
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	6 / 12	GLY A 722 GLN A 725 MET A 756 LEU A 763 ARG A 766 MET A 801	WOW A 1 ( 4.3A) WOW A 1 ( 4.1A) WOW A 1 ( 4.1A) WOW A 1 ( 4.0A) WOW A 1 (-3.8A) WOW A 1 (-4.2A)	0.90A	54.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	9 / 12	LEU A 718 ASN A 719 GLY A 722 MET A 756 LEU A 763 ARG A 766 MET A 801 THR A 894 PHE A 905	WOW A 1 (-4.2A) WOW A 1 (-3.3A) WOW A 1 ( 4.3A) WOW A 1 ( 4.1A) WOW A 1 ( 4.0A) WOW A 1 (-3.8A) WOW A 1 (-4.2A) WOW A 1 (-3.9A) WOW A 1 (-4.6A)	0.81A	54.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	3s5n	4-HYDROXY-2-OXOGLUTA RATE ALDOLASE, MITOCHONDRIAL (Homo sapiens)	5 / 12	LEU A 220 LEU A 107 MET A 134 ILE A 205 PHE A 226	None	1.41A	20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	4cak	INTEGRIN ALPHA-IIB INTEGRIN BETA-3 (Homo sapiens)	5 / 12	GLY B 293 LEU B 246 ARG A 317 GLN B 228 THR A 413	None	1.32A	16.23
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	ASN A 564 GLY A 567 LEU A 627 THR A 739 PHE A 749	MOF A 801 (-3.0A) MOF A 801 (-3.4A) None MOF A 801 (-3.9A) MOF A 801 (-4.4A)	1.44A	98.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	ASN A 564 GLY A 568 GLN A 570 MET A 601 THR A 739 ILE A 747 PHE A 749	MOF A 801 (-3.0A) None MOF A 801 (-2.9A) MOF A 801 (-3.7A) MOF A 801 (-3.9A) MOF A 801 ( 4.4A) MOF A 801 (-4.4A)	1.14A	98.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	11 / 12	LEU A 563 ASN A 564 GLY A 567 GLN A 570 MET A 601 LEU A 608 ARG A 611 MET A 646 THR A 739 ILE A 747 PHE A 749	MOF A 801 (-3.9A) MOF A 801 (-3.0A) MOF A 801 (-3.4A) MOF A 801 (-2.9A) MOF A 801 (-3.7A) MOF A 801 ( 4.6A) MOF A 801 (-4.2A) MOF A 801 (-4.4A) MOF A 801 (-3.9A) MOF A 801 ( 4.4A) MOF A 801 (-4.4A)	0.43A	98.41
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	4u8d	SORCIN (Homo sapiens)	5 / 12	LEU A 58 GLY A 62 LEU A 35 ILE A 160 PHE A 156	None	1.27A	20.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	ASN A 770 GLY A 774 GLN A 776 THR A 945 PHE A 956	CV7 A1987 (-3.1A) None CV7 A1987 (-3.0A) CV7 A1987 (-3.1A) CV7 A1987 ( 4.7A)	1.34A	54.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	9 / 12	LEU A 769 ASN A 770 GLN A 776 MET A 807 LEU A 814 ARG A 817 MET A 852 THR A 945 PHE A 956	CV7 A1987 (-4.1A) CV7 A1987 (-3.1A) CV7 A1987 (-3.0A) CV7 A1987 ( 3.9A) CV7 A1987 ( 4.0A) CV7 A1987 (-3.7A) CV7 A1987 ( 3.7A) CV7 A1987 (-3.1A) CV7 A1987 ( 4.7A)	0.67A	54.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	4wmh	HEME OXYGENASE 2 (Homo sapiens)	5 / 12	MET A 158 LEU A 97 MET A 206 THR A 41 PHE A 227	None	1.39A	21.67
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	5bo6	SIA-ALPHA-2,3-GAL-BE TA-1,4-GLCNAC-R:ALPH A 2,8-SIALYLTRANSFERAS E (Homo sapiens)	5 / 12	GLY A 302 LEU A 299 GLN A 100 THR A 372 ILE A 316	CDP A 411 (-3.3A) None None None None	1.39A	21.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	5hzw	MALTOSE-BINDING PERIPLASMIC PROTEIN,ENDOGLIN (Escherichia coli; Homo sapiens)	5 / 12	LEU A 130 GLY A 124 GLN A 127 ILE A 115 PHE A 122	None	1.43A	15.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	5ikr	PROSTAGLANDIN G/H SYNTHASE 2 (Homo sapiens)	5 / 12	LEU A 534 ASN A 537 GLY A 536 GLN A 208 ILE A 337	None	1.10A	17.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	ASN A 770 GLY A 774 GLN A 776 THR A 945 PHE A 956	ECV A1101 (-3.1A) None ECV A1101 (-2.9A) ECV A1101 (-3.2A) ECV A1101 ( 4.7A)	1.29A	45.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	GLN A 776 MET A 807 LEU A 814 ARG A 817 MET A 852	ECV A1101 (-2.9A) ECV A1101 (-3.6A) ECV A1101 (-4.1A) ECV A1101 (-4.0A) ECV A1101 (-3.7A)	1.31A	45.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	8 / 12	LEU A 769 ASN A 770 GLN A 776 MET A 807 LEU A 814 ARG A 817 THR A 945 PHE A 956	ECV A1101 (-4.7A) ECV A1101 (-3.1A) ECV A1101 (-2.9A) ECV A1101 (-3.6A) ECV A1101 (-4.1A) ECV A1101 (-4.0A) ECV A1101 (-3.2A) ECV A1101 ( 4.7A)	0.57A	45.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	5n6c	D-3-PHOSPHOGLYCERATE DEHYDROGENASE (Homo sapiens)	5 / 12	LEU A 217 ASN A 218 GLY A 215 LEU A 151 GLN A 224	None	1.43A	16.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	5nzp	D-3-PHOSPHOGLYCERATE DEHYDROGENASE (Homo sapiens)	5 / 12	LEU B 217 ASN B 218 GLY B 215 LEU B 151 GLN B 224	None None None 9EW B 301 ( 4.8A) None	1.30A	22.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_1 (GLUCOCORTICOID RECEPTOR)	6au8	GOLGI TO ER TRAFFIC PROTEIN 4 HOMOLOG LARGE PROLINE-RICH PROTEIN BAG6 (Homo sapiens)	5 / 12	GLN C1023 LEU A 266 THR A 220 ILE A 226 PHE A 232	None	1.46A	13.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_2 (GLUCOCORTICOID RECEPTOR)	2ayn	UBIQUITIN CARBOXYL-TERMINAL HYDROLASE 14 (Homo sapiens)	3 / 3	MET A 180 MET A 206 TYR A 150	None	1.26A	20.34
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_2 (GLUCOCORTICOID RECEPTOR)	2dao	TRANSCRIPTION FACTOR ETV6 (Homo sapiens)	3 / 3	MET A 97 MET A 90 TYR A 16	None	1.32A	18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_2 (GLUCOCORTICOID RECEPTOR)	2gjt	RECEPTOR-TYPE TYROSINE-PROTEIN PHOSPHATASE PTPRO (Homo sapiens)	3 / 3	MET A1024 MET A 984 TYR A 992	None	1.42A	19.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_2 (GLUCOCORTICOID RECEPTOR)	3dh1	TRNA-SPECIFIC ADENOSINE DEAMINASE 2 (Homo sapiens)	3 / 3	MET A 30 MET A 48 TYR A 158	None	1.39A	20.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_2 (GLUCOCORTICOID RECEPTOR)	3hqi	SPECKLE-TYPE POZ PROTEIN (Homo sapiens)	3 / 3	MET A 255 MET A 288 TYR A 280	None	1.19A	20.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_2 (GLUCOCORTICOID RECEPTOR)	3htm	SPECKLE-TYPE POZ PROTEIN (Homo sapiens)	3 / 3	MET A 255 MET A 288 TYR A 280	None	1.25A	19.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_2 (GLUCOCORTICOID RECEPTOR)	3kuq	RHO GTPASE-ACTIVATING PROTEIN 7 (Homo sapiens)	3 / 3	MET A1099 MET A1128 TYR A1153	None	1.17A	24.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_2 (GLUCOCORTICOID RECEPTOR)	4eoz	SPECKLE-TYPE POZ PROTEIN (Homo sapiens)	3 / 3	MET A 255 MET A 288 TYR A 280	None	1.23A	19.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_2 (GLUCOCORTICOID RECEPTOR)	4j8z	SPECKLE-TYPE POZ PROTEIN (Homo sapiens)	3 / 3	MET A 255 MET A 288 TYR A 280	None	1.27A	21.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_2 (GLUCOCORTICOID RECEPTOR)	4x0r	INTERFERON-INDUCED GTP-BINDING PROTEIN MX2 (Homo sapiens)	3 / 3	MET B 155 MET B 112 TYR B 212	None	1.34A	21.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_2 (GLUCOCORTICOID RECEPTOR)	5vni	PROTEIN TRANSPORT PROTEIN SEC23A (Homo sapiens)	3 / 3	MET A 287 MET A 360 TYR A 370	None	1.21A	16.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_2 (GLUCOCORTICOID RECEPTOR)	6eot	DIPEPTIDYL PEPTIDASE 8 (Homo sapiens)	3 / 3	MET A 722 MET A 813 TYR A 787	None	1.34A	15.14
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_2 (GLUCOCORTICOID RECEPTOR)	6fkq	NETRIN-1 (Homo sapiens)	3 / 3	MET A 210 MET A 159 TYR A 272	SO4 A 510 ( 4.4A) None None	1.39A	20.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_I_HCYI900_2 (GLUCOCORTICOID RECEPTOR)	6fuy	VINCULIN (Homo sapiens)	3 / 3	MET A 94 MET A 26 TYR A 107	None	1.16A	14.90
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4P6X_K_HCYK900_1 (GLUCOCORTICOID RECEPTOR)	1m1l	SUPPRESSOR OF FUSED (Homo sapiens)	5 / 12	MET A 177 GLY A 158 GLN A 217 ARG A 224 PHE A 155	None	1.48A	19.20
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_K_HCYK900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	6 / 12	ASN A 705 GLY A 708 GLN A 711 MET A 742 ARG A 752 PHE A 891	BHM A 1 (-3.6A) BHM A 1 ( 3.8A) BHM A 1 (-2.2A) BHM A 1 ( 4.0A) BHM A 1 (-3.8A) None	0.84A	49.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_K_HCYK900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	5 / 12	GLN A 711 MET A 742 ARG A 752 GLN A 783 MET A 787	BHM A 1 (-2.2A) BHM A 1 ( 4.0A) BHM A 1 (-3.8A) None BHM A 1 (-3.6A)	1.24A	49.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_K_HCYK900_1 (GLUCOCORTICOID RECEPTOR)	2ax9	ANDROGEN RECEPTOR (Homo sapiens)	5 / 12	GLY A 708 GLN A 711 MET A 742 ARG A 752 MET A 787	BHM A 1 ( 3.8A) BHM A 1 (-2.2A) BHM A 1 ( 4.0A) BHM A 1 (-3.8A) BHM A 1 (-3.6A)	0.91A	49.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_K_HCYK900_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	7 / 12	ASN A 719 GLY A 722 MET A 756 ARG A 766 MET A 801 THR A 894 PHE A 905	WOW A 1 (-3.3A) WOW A 1 ( 4.3A) WOW A 1 ( 4.1A) WOW A 1 (-3.8A) WOW A 1 (-4.2A) WOW A 1 (-3.9A) WOW A 1 (-4.6A)	0.74A	54.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_K_HCYK900_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	6 / 12	ASN A 719 TRP A 755 MET A 756 MET A 801 THR A 894 PHE A 905	WOW A 1 (-3.3A) None WOW A 1 ( 4.1A) WOW A 1 (-4.2A) WOW A 1 (-3.9A) WOW A 1 (-4.6A)	1.18A	54.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_K_HCYK900_1 (GLUCOCORTICOID RECEPTOR)	3kba	PROGESTERONE RECEPTOR (Homo sapiens)	5 / 12	GLY A 722 GLN A 725 MET A 756 ARG A 766 MET A 801	WOW A 1 ( 4.3A) WOW A 1 ( 4.1A) WOW A 1 ( 4.1A) WOW A 1 (-3.8A) WOW A 1 (-4.2A)	0.92A	54.30
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_K_HCYK900_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	ASN A 564 GLY A 568 TRP A 600 MET A 601 THR A 739 ILE A 747 PHE A 749	MOF A 801 (-3.0A) None None MOF A 801 (-3.7A) MOF A 801 (-3.9A) MOF A 801 ( 4.4A) MOF A 801 (-4.4A)	0.95A	98.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_K_HCYK900_1 (GLUCOCORTICOID RECEPTOR)	4p6w	GLUCOCORTICOID RECEPTOR (Homo sapiens)	11 / 12	MET A 560 ASN A 564 GLY A 567 GLN A 570 TRP A 600 MET A 601 ARG A 611 MET A 646 THR A 739 ILE A 747 PHE A 749	MOF A 801 (-3.9A) MOF A 801 (-3.0A) MOF A 801 (-3.4A) MOF A 801 (-2.9A) None MOF A 801 (-3.7A) MOF A 801 (-4.2A) MOF A 801 (-4.4A) MOF A 801 (-3.9A) MOF A 801 ( 4.4A) MOF A 801 (-4.4A)	0.41A	98.41
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_K_HCYK900_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	8 / 12	ASN A 770 GLN A 776 TRP A 806 MET A 807 ARG A 817 MET A 852 THR A 945 PHE A 956	CV7 A1987 (-3.1A) CV7 A1987 (-3.0A) None CV7 A1987 ( 3.9A) CV7 A1987 (-3.7A) CV7 A1987 ( 3.7A) CV7 A1987 (-3.1A) CV7 A1987 ( 4.7A)	0.72A	54.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_K_HCYK900_1 (GLUCOCORTICOID RECEPTOR)	4udb	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	ASN A 770 GLY A 774 TRP A 806 THR A 945 PHE A 956	CV7 A1987 (-3.1A) None None CV7 A1987 (-3.1A) CV7 A1987 ( 4.7A)	1.12A	54.04
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_K_HCYK900_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	7 / 12	ASN A 770 GLN A 776 TRP A 806 MET A 807 ARG A 817 THR A 945 PHE A 956	ECV A1101 (-3.1A) ECV A1101 (-2.9A) None ECV A1101 (-3.6A) ECV A1101 (-4.0A) ECV A1101 (-3.2A) ECV A1101 ( 4.7A)	0.45A	45.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_K_HCYK900_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	ASN A 770 GLY A 774 TRP A 806 THR A 945 PHE A 956	ECV A1101 (-3.1A) None None ECV A1101 (-3.2A) ECV A1101 ( 4.7A)	1.04A	45.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	4P6X_K_HCYK900_1 (GLUCOCORTICOID RECEPTOR)	5mwp	MINERALOCORTICOID RECEPTOR (Homo sapiens)	5 / 12	GLN A 776 TRP A 806 MET A 807 ARG A 817 MET A 852	ECV A1101 (-2.9A) None ECV A1101 (-3.6A) ECV A1101 (-4.0A) ECV A1101 (-3.7A)	1.29A	45.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HGC_A_HCYA501_1 (SERPIN)	2aw5	NADP-DEPENDENT MALIC ENZYME (Homo sapiens)	5 / 12	VAL A 276 ALA A 274 ARG A 155 ILE A 270 ASN A 454	None	1.44A	20.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HGC_A_HCYA501_1 (SERPIN)	3o65	PUTATIVE ATAXIN-3-LIKE PROTEIN (Homo sapiens)	5 / 12	PHE A 127 LYS A 1 ILE A 5 PHE A 132 ASN A 133	None	1.34A	18.93
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HGC_A_HCYA501_1 (SERPIN)	3u1k	POLYRIBONUCLEOTIDE NUCLEOTIDYLTRANSFERA SE 1, MITOCHONDRIAL (Homo sapiens)	5 / 12	ARG A 617 PHE A 647 ILE A 639 PHE A 620 ASN A 627	None	1.25A	21.98
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5HGC_A_HCYA501_1 (SERPIN)	4c41	CORTICOSTEROID-BINDI NG GLOBULIN (Homo sapiens)	5 / 12	THR A 240 PHE A 242 ILE A 263 SER A 267 PHE A 366	None	0.80A	41.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HGC_A_HCYA501_1 (SERPIN)	4fdh	CYTOCHROME P450 11B2, MITOCHONDRIAL (Homo sapiens)	5 / 12	PRO A 322 THR A 475 ILE A 481 SER A 494 PHE A 328	None	1.35A	20.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HGC_A_HCYA501_1 (SERPIN)	4fzd	SERINE/THREONINE-PRO TEIN KINASE MST4 (Homo sapiens)	5 / 12	PRO B 115 PHE B 273 ILE B 121 GLN B 120 PHE B 247	None	1.40A	21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HGC_A_HCYA501_1 (SERPIN)	4fzd	SERINE/THREONINE-PRO TEIN KINASE MST4 (Homo sapiens)	5 / 12	THR B 244 PHE B 273 ILE B 121 GLN B 120 PHE B 247	None	1.36A	21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HGC_A_HCYA501_1 (SERPIN)	4n40	PROTEIN ECT2 (Homo sapiens)	5 / 12	VAL A 123 ALA A 68 ILE A 66 GLN A 62 PHE A 76	None	1.07A	20.61
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HGC_A_HCYA501_1 (SERPIN)	4pj6	LEUCYL-CYSTINYL AMINOPEPTIDASE (Homo sapiens)	5 / 12	VAL A 194 THR A 292 LYS A 318 ILE A 319 SER A 329	None	1.28A	18.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HGC_A_HCYA501_1 (SERPIN)	5bwa	ORNITHINE DECARBOXYLASE (Homo sapiens)	5 / 12	VAL A 192 THR A 63 PHE A 65 ILE A 109 GLN A 129	None	1.29A	23.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HGC_A_HCYA501_1 (SERPIN)	5v8w	INTEGRATOR COMPLEX SUBUNIT 9 (Homo sapiens)	5 / 12	VAL A 608 THR A 597 PHE A 654 ILE A 589 PHE A 594	None	1.40A	15.60
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HGC_A_HCYA501_1 (SERPIN)	6bdz	DISINTEGRIN AND METALLOPROTEINASE DOMAIN-CONTAINING PROTEIN 10 (Homo sapiens)	5 / 12	ALA A 315 ARG A 321 THR A 319 PHE A 300 GLN A 307	None None None None NAG A 701 (-3.8A)	1.41A	11.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HGC_A_HCYA501_1 (SERPIN)	6bq1	PHOSPHATIDYLINOSITOL 4-KINASE III ALPHA (PI4KA) (Homo sapiens)	5 / 12	ALA A2033 THR A2053 PHE A1980 ILE A1864 GLN A1863	None	1.34A	0.00